The Spatial Relationship between Apparent Diffusion Coefficient and Standardized Uptake Value of 18F-Fluorodeoxyglucose Has a Crucial Influence on the Numeric Correlation of Both Parameters in PET/MRI of Lung Tumors.
Alexander Walter SauterBram StieltjesThomas WeikertSergios GatidisMark WieseMarkus KlarhöferDamian WildDidier LardinoisJens BremerichGregor SommerPublished in: Contrast media & molecular imaging (2017)
The minimum apparent diffusion coefficient (ADCmin) derived from diffusion-weighted MRI (DW-MRI) and the maximum standardized uptake value (SUVmax) of FDG-PET are markers of aggressiveness in lung cancer. The numeric correlation of the two parameters has been extensively studied, but their spatial interplay is not well understood. After FDG-PET and DW-MRI coregistration, values and location of ADCmin- and SUVmax-voxels were analyzed. The upper limit of the 95% confidence interval for registration accuracy of sequential PET/MRI was 12 mm, and the mean distance (D) between ADCmin- and SUVmax-voxels was 14.0 mm (average of two readers). Spatial mismatch (D > 12 mm) between ADCmin and SUVmax was found in 9/25 patients. A considerable number of mismatch cases (65%) was also seen in a control group that underwent simultaneous PET/MRI. In the entire patient cohort, no statistically significant correlation between SUVmax and ADCmin was seen, while a moderate negative linear relationship (r = -0.5) between SUVmax and ADCmin was observed in tumors with a spatial match (D ≤ 12 mm). In conclusion, spatial mismatch between ADCmin and SUVmax is found in a considerable percentage of patients. The spatial connection of the two parameters SUVmax and ADCmin has a crucial influence on their numeric correlation.
Keyphrases
- contrast enhanced
- diffusion weighted imaging
- positron emission tomography
- pet ct
- computed tomography
- diffusion weighted
- magnetic resonance imaging
- pet imaging
- end stage renal disease
- newly diagnosed
- magnetic resonance
- ejection fraction
- prognostic factors
- peritoneal dialysis
- chronic kidney disease
- multidrug resistant
- patient reported outcomes